CompletedNot Applicable

Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)

France133 participantsStarted 2008-01

Plain-language summary

Cohort CNC-PPNAD will be investigated with clinical, genetic, biological and imaging work-up every year during 3 years. Cohort L-MC will be investigated clinically at inclusion and a PERKAR1A genotype will be performed.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: CNC group : * patient with the CARNEY complex (CNC) or the primary pigmented nodular adrenocortical disease (PPNAD) or a germinal mutation of the gene of CARNEY Complex or PPNAD. * No age criteria * Inform consent of the patient or the parental authority collected * Realization of a preliminary medical examination * Affiliated with a social security system ( profit or having right) MC-L group : * Patient with periorificial lentiginosis or cardiac myxoma * or previous history of periorificial lentiginosis or cardiac myxoma * age \> or = 18 years old * Realization of a preliminary medical examination * Affiliated with a social security system ( profit or having right) Exclusion criteria : CNC group and MC-L group: * refusal or incapacity to take part in the study

What they're measuring

To assess the clinical manifestations of the CARNEY Complex (CNC) and/or the primary pigmented nodular adrenocortical disease (PPNAD)

Timeframe: 6 months

Trial details

NCT IDNCT00668291

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-05

View on ClinicalTrials.gov More Primary; Complex trials